Clinical Trials Browser

Phase 3 × nintedanib × Gastrointestinal × Clear all

NCT02149108 2017-07-21

Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)

Phase 3 Completed

768 enrolled 10 charts

Gastrointestinal

Colorectal Neoplasms